KRAS Mutants.....
while i have no idea what ".....a Colon Cancer GEMM-Derived Orthotopic Transplant Model for Drug Discovery and Validation" is and neither will you by reading this "abstract "-unless you already know what it is) but you might learn a little about Kras mutation in this brief synopsis
http://clincancerres.aacrjournals.org/content/early/2013/02/12/1078-0432.CCR-12-2307.abstract
Comments
-
That's me (KRAS mutant), but
That's me (KRAS mutant), but at least I'm BRAF wild-type and only Grade 2. Those last 2 make my prognosis a little beter than BRAF mutant and/or Grade 3.
0 -
thanks steve
always interesting
we should have kept a count of how many papers we have read, must be over 1000
hugs,
pete
0 -
The Study say: "Further
The Study say: "Further analyses revealed enrichment for numerous disease-relevant biological pathways, including glucose metabolism. Functional assessment in vitro and in vivo validated this finding and highlighted the dependence of Kras mutant CRC on oncogenic signaling and on aerobic glycolysis."
Seems like giving up all sugars and most carbs was a good call, despite the insistence of my oncologist that I was making a mistake.0 -
Don't know if this will be of use:renw said:The Study say: "Further
The Study say: "Further analyses revealed enrichment for numerous disease-relevant biological pathways, including glucose metabolism. Functional assessment in vitro and in vivo validated this finding and highlighted the dependence of Kras mutant CRC on oncogenic signaling and on aerobic glycolysis."
Seems like giving up all sugars and most carbs was a good call, despite the insistence of my oncologist that I was making a mistake.http://mct.aacrjournals.org/content/12/2/151
or this:
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0025132
(might want to look at "Discussion" part on this one unless you're science-literate,which i'm not; i know this one's on "wild" but maybe there's info here that might be of use anyway)
Also,maybe something of substance will result fromthis just announced collaboration between Vanderbilt and Gen Elec
http://eon.businesswire.com/news/eon/20130212006193/en/GE/Vanderbilt/cancer
0 -
summary of KRAS and BRAF mutation...
The following article helped me better understand KRAS and BRAF tests and the implications to treatment for CRCm.
0 -
KRAS,BRAF,PIK3CA gene Mutations:Phil64 said:summary of KRAS and BRAF mutation...
The following article helped me better understand KRAS and BRAF tests and the implications to treatment for CRCm.
some potential has been found with something called "gabexate mesilate", tho may not be in US
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 122K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 398 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 673 Leukemia
- 794 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 238 Multiple Myeloma
- 7.2K Ovarian Cancer
- 63 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 542 Sarcoma
- 736 Skin Cancer
- 656 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards